ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Panel Debates Whether DCIS Needs A New Name

September 25, 2009

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

In Brief: Francis Giles named deputy director of Lurie Cancer Center

October 17, 2014

Henry Neil, Natcher’s right arm, Back In The Job

March 25, 1988

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003